Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2009
05/14/2009WO2009017854A3 Sensor system and method
05/14/2009WO2009014761A3 Method for predicting response to tamoxifen
05/14/2009WO2009004189A9 Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof
05/14/2009WO2008140595A3 Synthetic trivalent haptens, complexes thereof, and uses therefor
05/14/2009WO2008097461A3 Hepcidin and hepcidin antibodies
05/14/2009WO2007059117A3 Discover biological features using composite images
05/14/2009WO2007056043A3 Use of potassium channels for identifying compounds that have an insecticidal effect
05/14/2009WO2007021756A3 Methods for characterizing biological molecule modulators
05/14/2009WO2007013949A3 Asbestos exposure, pleural mesothelioma, and serum osteopontin levels
05/14/2009WO2006113429A3 Viral inhibitors
05/14/2009WO2006062427A8 Method for quantitatively detecting biological toxins
05/14/2009WO2005053512A3 Animal models of pancreatic adenocarcinoma and uses therefor
05/14/2009US20090125268 Biosensor Coding System
05/14/2009US20090125248 System, Method and computer program product for integrated analysis and visualization of genomic data
05/14/2009US20090125247 Gene expression markers of recurrence risk in cancer patients after chemotherapy
05/14/2009US20090125245 Methods For Rapid Forensic Analysis Of Mitochondrial DNA
05/14/2009US20090125244 Broad-based neurotoxin-related gene mutation association from a gene transcript test
05/14/2009US20090125242 Tomographic phase microscopy
05/14/2009US20090125241 Real time water analysis system for metals, chemicals, radiological and biological materials (cbrnme) within water
05/14/2009US20090124795 Mitochondrial Dosimeter
05/14/2009US20090124684 Stimulation Of CPT-1 As A Means To Reduce Weight
05/14/2009US20090124608 CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same
05/14/2009US20090124571 Method for the synthesis of oligonucleotide derivatives
05/14/2009US20090124569 Inhibition and treatment of prostate cancer metastasis
05/14/2009US20090124537 Screening method for bone morphogenetic mimetics
05/14/2009US20090124513 Multiplex Biosensor
05/14/2009US20090124511 Antibody complexes and methods for immunolabeling
05/14/2009US20090124510 Quantitative Determination of Proteins from Formalin-Fixed Tissue
05/14/2009US20090124026 Use of Perfluoropolymer Submicrometric Latexes in the Determination of Molecular Interactions By Laser Light Scattering (Lls)
05/14/2009US20090124025 Nanowire-based sensor configurations
05/14/2009US20090124024 Optical-waveguide sensor chip, method of manufacturing the same, method of measuring substance, substance-measuring kit and optical-waveguide sensor
05/14/2009US20090124023 Reagens for the Detection of Protein Acetylation Signaling Pathways
05/14/2009US20090124022 Antibodies that bind to mammalian ngal and uses thereof
05/14/2009US20090124021 Device for Containing, Reacting and Measuring, and Method of Containing, Reacting and Measuring
05/14/2009US20090124019 Absolute method for the quantification of organic compounds
05/14/2009US20090124018 tablets having stress-preventative, anti-stress, nootropic, and neuroprotective effects; each tablet comprising microcapsulated glycine comprising non-agglomerated crystals of amino-acetic acid covered with a polymeric film of water-soluble methylcellulose, magnesium stearate
05/14/2009US20090124017 Sampling Device and Method for the Rapid Detection of Proteins in Mold, Allergens or Other Protein-Containing Substances
05/14/2009US20090124016 Nanopatterned surfaces and related methods for selective adhesion, sensing and separation
05/14/2009US20090123953 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
05/14/2009US20090123952 Method of Measuring Amyloid-Beta Peptides
05/14/2009US20090123951 Method Of Diagnosing A Body Weight Condition Or Predisposition
05/14/2009US20090123950 Generation And Profiling Of Fully Human Hucal Gold®-Derived Therapeutic Antibodies Specific For Human CD38
05/14/2009US20090123949 Methods for determining the prognosis for cancer patients using tucan
05/14/2009US20090123948 highly sensitive enzyme immunoassay (EIA) for measuring IgG antibody against extracellular protein kinase A (ECPKA)
05/14/2009US20090123947 Analytical Sandwich Test for determining NT-proBNP
05/14/2009US20090123946 Immunoassays and kits for the detection of ngal
05/14/2009US20090123945 Cholinergic/serotoninergic receptor and uses thereof
05/14/2009US20090123944 Bioassays
05/14/2009US20090123943 Characterization and Identification of Unique Human Adiponectin Isoforms and Antibodies
05/14/2009US20090123942 Electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes
05/14/2009US20090123941 Method and kit for detecting the early onset of renal tubular cell injury
05/14/2009US20090123940 Molecules involved in synaptogenesis and uses therefor
05/14/2009US20090123939 Biologically enhanced electrically-active magnetic nanoparticles for concentration, separation, and detection applications
05/14/2009US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist
05/14/2009US20090123937 Methods of selecting epidermal growth factor receptor (EGFR) binding agents
05/14/2009US20090123936 Conformationally abnormal forms of tau proteins and specific antibodies thereto
05/14/2009US20090123934 Inhibition of polo kinase by matrimony maintains G2 arrest in the meiotic cell cycle
05/14/2009US20090123931 Identification of tissue for debridement
05/14/2009US20090123927 Isolation of precursor cells and their use for tissue repair
05/14/2009US20090123922 Bead Bound Combinatorial Oligonucleoside Phosphorothioate And Phosphorodithioate Aptamer Libraries
05/14/2009US20090123921 Immunoglobulin libraries
05/14/2009US20090123914 Genomic Assay
05/14/2009US20090123910 Method of efficient extraction of protein from cells
05/14/2009US20090123670 Forming a liquid crystal device including contacting an aqueous solution comprising a surfactant and a receptor molecule with a top surface of a liquid crystal; use studying phospholipids reactions and interactions
05/14/2009US20090123565 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
05/14/2009US20090123533 Compositions and methods for cancer diagnosis and therapy
05/14/2009US20090123500 Active immunization using a siderophore receptor protein
05/14/2009US20090123483 Anti-ccr7 receptor antibodies for the treatment of cancer
05/14/2009US20090123478 Human antibody molecules for IL-13
05/14/2009US20090123473 Human bnp immunospecific antibodies
05/14/2009US20090123462 Fgfr agonists
05/14/2009US20090123461 Human podocalyxin alternative-spliced forms and uses thereof
05/14/2009US20090123459 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
05/14/2009US20090123457 Lumican proteoglycan in the diagnosis and treatment of atherosclerosis
05/14/2009US20090123456 determining whether an antibody is an agonist selective for nicotinic receptors, inhibits release of a proinflammatory cytokine from a mammalian cell, and if the antibody is reactive with nicotinic receptors; drug screening
05/14/2009US20090123439 Diagnostic and prognosis methods for cancer stem cells
05/14/2009US20090123434 Cellular upregulation of VEGF receptor expression using nanofibrillar articles
05/14/2009US20090123427 Method of Treating a Malignancy in a Subject and a Pharmaceutical Composition for Use in Same
05/14/2009US20090123415 Diagnosis, treatment, and prevention of vascular disorders using il-1 autoantibodies
05/14/2009US20090123411 Molecular Fingerprints With Enhanced Identifying Capability, Method for Preparing Same and Use Thereof
05/14/2009US20090123382 Light emitting microorganisms and cells for diagnosis and therapy of tumors
05/14/2009US20090123379 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
05/14/2009US20090123377 Method for Testing Substances or Mixtures of Substances,Use of Said Method and Corresponding Test Kits
05/14/2009US20090123375 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration
05/14/2009US20090123374 Methods for determining cancer resistance to histone deacetylase inhibitors
05/14/2009US20090123368 Use of dkk-1 protein in the cancer diagnosis
05/14/2009US20090123340 Water quality monitoring device and method
05/14/2009US20090123337 Cartridge
05/14/2009US20090123336 Microfluidic chips for rapid multiplex elisa
05/14/2009US20090122299 Optical Sub Wavelength Super Resolution Imaging System and Method
05/14/2009US20090121193 Surface enhanced spectroscopy-active composite nanoparticles
05/14/2009US20090121031 Method of minimizing visible coloration of substrate
05/14/2009US20090121009 Apparatus and Methods for Monitoring Transfusion of Blood
05/14/2009US20090120253 Method and apparatus for cutting off glass panes from a continuously produced glass sheet
05/14/2009US20090120190 Method and a system for monitoring structural changes of a fiber web
05/14/2009US20090120167 Device and a Method for Analysis of an Article of Food by Means of a Test Cup
05/14/2009US20090120158 Articles Of Manufacture Containing Increased Stability Low Concentration Gases And Methods Of Making And Using The Same
05/14/2009DE102007000679A1 Verfahren und Vorrichtung zum Erfassen eines Risses und/oder eines Elastizitätsmoduls einer Materialbahn Method and apparatus for detecting a crack and / or a modulus of elasticity of a material web
05/14/2009CA2743032A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
05/14/2009CA2741911A1 Quantification of an absorber through a scattering medium